Published in Cancer Res on January 15, 2007
The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer (2009) 9.01
Tumour necrosis factor and cancer. Nat Rev Cancer (2009) 6.27
Rethinking ovarian cancer: recommendations for improving outcomes. Nat Rev Cancer (2011) 5.28
"Re-educating" tumor-associated macrophages by targeting NF-kappaB. J Exp Med (2008) 4.38
Role of chemokines in tumor growth. Cancer Lett (2007) 3.36
Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) (2010) 2.99
Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res (2011) 2.85
Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res (2014) 2.51
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest (2009) 2.42
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer (2013) 1.93
Cancer-related inflammation. J Clin Immunol (2012) 1.91
Inflammation: a driving force speeds cancer metastasis. Cell Cycle (2009) 1.78
Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol (2015) 1.65
SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood (2008) 1.63
Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin (2008) 1.60
B regulatory cells and the tumor-promoting actions of TNF-α during squamous carcinogenesis. Proc Natl Acad Sci U S A (2011) 1.58
Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements. Cell Mol Life Sci (2010) 1.58
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. J Clin Invest (2011) 1.58
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res (2011) 1.55
TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest (2012) 1.52
Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice. PLoS One (2014) 1.47
CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer. Cancer Res (2011) 1.42
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev (2012) 1.31
The complexities of obesity and diabetes with the development and progression of pancreatic cancer. Biochim Biophys Acta (2010) 1.29
Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res (2009) 1.25
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation. Carcinogenesis (2011) 1.20
Low levels of tumor necrosis factor alpha increase tumor growth by inducing an endothelial phenotype of monocytes recruited to the tumor site. Cancer Res (2009) 1.17
Effect of high-dose intravenous vitamin C on inflammation in cancer patients. J Transl Med (2012) 1.09
Tumor-associated macrophages contribute to tumor progression in ovarian cancer. Front Oncol (2014) 1.08
CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks. Oncogene (2015) 1.07
The peritoneal tumour microenvironment of high-grade serous ovarian cancer. J Pathol (2012) 1.07
Identification of TNF-alpha and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array. Br J Cancer (2009) 1.04
Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol (2014) 1.01
Vaccinia virus induces programmed necrosis in ovarian cancer cells. Mol Ther (2013) 1.01
Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. J Immunol (2013) 1.00
Murine CD27(-) Vγ6(+) γδ T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages. Proc Natl Acad Sci U S A (2014) 1.00
Gastric carcinogenesis. World J Gastroenterol (2012) 0.97
Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization. Clin Dev Immunol (2011) 0.97
The expressions of MIF and CXCR4 protein in tumor microenvironment are adverse prognostic factors in patients with esophageal squamous cell carcinoma. J Transl Med (2013) 0.97
Quantifying crosstalk among interferon-γ, interleukin-12, and tumor necrosis factor signaling pathways within a TH1 cell model. Sci Signal (2012) 0.97
UVB and proinflammatory cytokines synergistically activate TNF-alpha production in keratinocytes through enhanced gene transcription. J Invest Dermatol (2008) 0.95
Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS One (2012) 0.95
Obesity, Diabetes, the Cardiorenal Syndrome, and Risk for Cancer. Cardiorenal Med (2012) 0.94
Human adipose tissue macrophages display activation of cancer-related pathways. J Biol Chem (2012) 0.93
Obesity, diabetes and aggressive prostate cancer hormone-naïve at initial diagnosis. Cent European J Urol (2014) 0.92
Cytokine patterns in brain tumour progression. Mediators Inflamm (2013) 0.92
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis. J Exp Clin Cancer Res (2015) 0.91
Microgenomics profile the endogenous angiogenic phenotype in subpopulations of aggressive melanoma. J Cell Biochem (2008) 0.91
Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects. BMC Cancer (2014) 0.90
TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat Cell Biol (2012) 0.89
Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches. Cancer Metastasis Rev (2015) 0.89
Involvement of autophagy in ovarian cancer: a working hypothesis. J Ovarian Res (2012) 0.89
Obesity and survival in population-based patients with pancreatic cancer in the San Francisco Bay Area. Cancer Causes Control (2012) 0.88
Optimizing molecular-targeted therapies in ovarian cancer: the renewed surge of interest in ovarian cancer biomarkers and cell signaling pathways. J Oncol (2012) 0.88
A multi-targeted approach to suppress tumor-promoting inflammation. Semin Cancer Biol (2015) 0.87
Sequential genetic change at the TP53 and chemokine receptor CXCR4 locus during transformation of human ovarian surface epithelium. Oncogene (2012) 0.87
Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) (2014) 0.86
The immune system in the pathogenesis of ovarian cancer. Crit Rev Immunol (2013) 0.86
Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells. Stem Cells (2015) 0.85
Inhibition of the inflammatory cytokine TNF-α increases adenovirus activity in ovarian cancer via modulation of cIAP1/2 expression. Mol Ther (2010) 0.85
Increased tumor necrosis factor receptor 1 expression in human colorectal adenomas. World J Gastroenterol (2012) 0.85
The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol (2012) 0.84
Retracted Targeted immune therapy of ovarian cancer. Cancer Metastasis Rev (2015) 0.84
An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response. BMC Genomics (2013) 0.83
The role of macrophage migration inhibitory factor in ocular surface disease pathogenesis after chemical burn in the murine eye. Mol Vis (2010) 0.83
Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors. Gene Ther (2008) 0.83
CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis. Oncotarget (2015) 0.83
The transcriptional signature of human ovarian carcinoma macrophages is associated with extracellular matrix reorganization. Oncotarget (2016) 0.83
Inflammatory cytokine tumor necrosis factor alpha confers precancerous phenotype in an organoid model of normal human ovarian surface epithelial cells. Neoplasia (2009) 0.83
Mechanistic Effects of Calcitriol in Cancer Biology. Nutrients (2015) 0.82
Anti-tumor effect of rutin on human neuroblastoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis. ScientificWorldJournal (2013) 0.82
Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer. Cancer Res (2015) 0.82
Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice. Neoplasia (2011) 0.82
Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours. Arch Med Sci (2012) 0.81
Cross-talk between receptor tyrosine kinase and tumor necrosis factor-α signaling networks regulates apoptosis but not proliferation. Mol Cell Proteomics (2012) 0.81
Targeting diphtheria toxin and TNF alpha expression in ovarian tumors using the H19 regulatory sequences. Int J Clin Exp Med (2010) 0.81
TNF-α promotes gallbladder cancer cell growth and invasion through autocrine mechanisms. Int J Mol Med (2014) 0.81
TNF-α gene knockout in triple negative breast cancer cell line induces apoptosis. Int J Mol Sci (2012) 0.80
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model. J Ovarian Res (2013) 0.80
Bone Marrow Cells in Acute Lymphoblastic Leukemia Create a Proinflammatory Microenvironment Influencing Normal Hematopoietic Differentiation Fates. Biomed Res Int (2015) 0.80
Monocyte-Induced Prostate Cancer Cell Invasion is Mediated by Chemokine ligand 2 and Nuclear Factor-κB Activity. J Clin Cell Immunol (2015) 0.80
Monocyte chemotactic protein-1 deficiency reduces spontaneous metastasis of Lewis lung carcinoma in mice fed a high-fat diet. Oncotarget (2016) 0.79
Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med (2014) 0.79
Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis. Int J Exp Pathol (2010) 0.79
Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer. Int J Mol Sci (2015) 0.79
Progressive obesity alters ovarian folliculogenesis with impacts on pro-inflammatory and steroidogenic signaling in female mice. Biol Reprod (2014) 0.79
Integrated transcriptomic and proteomic analysis identifies protein kinase CK2 as a key signaling node in an inflammatory cytokine network in ovarian cancer cells. Oncotarget (2016) 0.78
Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer. FASEB J (2013) 0.78
Correlation set analysis: detecting active regulators in disease populations using prior causal knowledge. BMC Bioinformatics (2012) 0.78
Retracted Links demystified: Periodontitis and cancer. Dent Res J (Isfahan) (2013) 0.77
Cystine Deprivation Triggers Programmed Necrosis in VHL-Deficient Renal Cell Carcinomas. Cancer Res (2016) 0.77
Cystine addiction of triple-negative breast cancer associated with EMT augmented death signaling. Oncogene (2016) 0.77
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer. Oncotarget (2015) 0.77
Genetic deletion of TNFR2 augments inflammatory response and blunts satellite-cell-mediated recovery response in a hind limb ischemia model. FASEB J (2014) 0.77
Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer. Cancers (Basel) (2011) 0.77
Type I IFN gene delivery suppresses regulatory T cells within tumors. Cancer Gene Ther (2014) 0.77
Expression of tumor necrosis factor-alpha-mediated genes predicts recurrence-free survival in lung cancer. PLoS One (2014) 0.77
Inhibition of KPNA4 attenuates prostate cancer metastasis. Oncogene (2016) 0.77
Pharmacological Inhibition of β3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity. Cancer Res (2015) 0.76
Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis. PLoS One (2016) 0.76
A system for stable expression of short interfering RNAs in mammalian cells. Science (2002) 35.21
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57
NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature (2004) 15.14
Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell (2006) 13.79
Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol (2003) 5.85
Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med (2006) 5.22
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med (1999) 4.41
The response of human epithelial cells to TNF involves an inducible autocrine cascade. Cell (2006) 3.57
Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol (2005) 2.81
CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res (2005) 2.38
Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur J Cancer (2004) 2.12
Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer (2006) 2.09
Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res (1985) 2.06
Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol (2003) 2.03
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest (1995) 1.91
Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice. Cancer Res (2004) 1.88
Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells. J Natl Cancer Inst (2002) 1.85
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther (2006) 1.69
Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. J Clin Invest (1993) 1.62
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res (2004) 1.56
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res (2005) 1.49
von Hippel-Lindau protein-mediated repression of tumor necrosis factor alpha translation revealed through use of cDNA arrays. Mol Cell Biol (2003) 1.37
Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway. Oncogene (2002) 1.23
Paradoxical effects of tumour necrosis factor in experimental ovarian cancer. Int J Cancer (1989) 1.22
Prognostic significance of vascular endothelial growth factor expression in ovarian cancer patients: a long-term follow-up. Int J Gynecol Cancer (2006) 1.14
Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur J Cancer (2006) 1.12
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer (2001) 1.01
IL-6 production in ovarian carcinoma is associated with histiotype and biological characteristics of the tumour and influences local immunity. Br J Cancer (2000) 0.98
Regulation of fibroblast growth factor-2 activity by human ovarian cancer tumor endothelium. Clin Cancer Res (2005) 0.92
Cancer-related inflammation. Nature (2008) 34.21
A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell (2007) 9.20
Petabyte-scale innovations at the European Nucleotide Archive. Nucleic Acids Res (2008) 5.21
Frequent activating mutations of PIK3CA in ovarian clear cell carcinoma. Am J Pathol (2009) 3.90
Priorities for nucleotide trace, sequence and annotation data capture at the Ensembl Trace Archive and the EMBL Nucleotide Sequence Database. Nucleic Acids Res (2007) 3.84
WU-Blast2 server at the European Bioinformatics Institute. Nucleic Acids Res (2003) 3.82
Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med (2012) 3.54
Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects. Am J Orthod Dentofacial Orthop (2003) 3.35
Interleukin-6 as a therapeutic target in human ovarian cancer. Clin Cancer Res (2011) 2.85
Development and mapping of SSR markers for maize. Plant Mol Biol (2002) 2.83
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res (2002) 2.71
Challenged to care: informal caregivers in a changing health system. Health Aff (Millwood) (2002) 2.48
Adverse childhood exposures and reported child health at age 12. Acad Pediatr (2009) 2.45
The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest (2009) 2.42
Nutrition and fluid balance must be taken seriously. BMJ (2013) 2.39
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood (2012) 2.37
Early treatment for Class II Division 1 malocclusion with the Twin-block appliance: a multi-center, randomized, controlled trial. Am J Orthod Dentofacial Orthop (2009) 2.34
Effect of early childhood adversity on child health. Arch Pediatr Adolesc Med (2006) 2.15
Public web-based services from the European Bioinformatics Institute. Nucleic Acids Res (2004) 2.15
Cancer-related inflammation. J Clin Immunol (2012) 1.91
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res (2011) 1.79
The tumor microenvironment at a glance. J Cell Sci (2012) 1.79
Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J Clin Oncol (2007) 1.78
A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res (2003) 1.78
Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases. Am J Surg Pathol (2009) 1.71
Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther (2006) 1.69
Gadolinium-enhanced magnetic resonance imaging: a useful radiological tool in diagnosing pediatric IBD. Inflamm Bowel Dis (2004) 1.58
Crosstalk between the canonical NF-κB and Notch signaling pathways inhibits Pparγ expression and promotes pancreatic cancer progression in mice. J Clin Invest (2011) 1.58
UTILLdb, a Pisum sativum in silico forward and reverse genetics tool. Genome Biol (2008) 1.56
A phase II study of etanercept (Enbrel), a tumor necrosis factor alpha inhibitor in patients with metastatic breast cancer. Clin Cancer Res (2004) 1.56
Identification of ZDHHC14 as a novel human tumour suppressor gene. J Pathol (2014) 1.55
A combined proteome and transcriptome analysis of developing Medicago truncatula seeds: evidence for metabolic specialization of maternal and filial tissues. Mol Cell Proteomics (2007) 1.55
A dynamic inflammatory cytokine network in the human ovarian cancer microenvironment. Cancer Res (2011) 1.55
Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol (2003) 1.55
Youth self-report of physical and sexual abuse: a latent class analysis. Child Abuse Negl (2010) 1.53
Inflammation and cancer: a double-edged sword. Cancer Cell (2007) 1.52
The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells. Cancer Res (2005) 1.49
Bortezomib therapy in patients with relapsed or refractory lymphoma: potential correlation of in vitro sensitivity and tumor necrosis factor alpha response with clinical activity. J Clin Oncol (2006) 1.45
Study of etanercept, a tumor necrosis factor-alpha inhibitor, in recurrent ovarian cancer. J Clin Oncol (2005) 1.45
Developmental haemostasis. Impact for clinical haemostasis laboratories. Thromb Haemost (2006) 1.44
Accumulation of microplastic on shorelines woldwide: sources and sinks. Environ Sci Technol (2011) 1.44
The chemokine network in cancer--much more than directing cell movement. Int J Dev Biol (2004) 1.42
Biodistribution, long-term survival, and safety of human adipose tissue-derived mesenchymal stem cells transplanted in nude mice by high sensitivity non-invasive bioluminescence imaging. Stem Cells Dev (2008) 1.42
Stromal genes discriminate preinvasive from invasive disease, predict outcome, and highlight inflammatory pathways in digestive cancers. Proc Natl Acad Sci U S A (2010) 1.41
RCVS modular CertAVP and ophthalmology. Vet Rec (2008) 1.39
Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med (2010) 1.38
Safety of medicines and the use of animals in research. Lancet (2011) 1.38
Importance of early neglect for childhood aggression. Pediatrics (2008) 1.37
Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol (2010) 1.36
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology (2013) 1.32
A modified medium that significantly improves the growth of human normal ovarian surface epithelial (OSE) cells in vitro. Lab Invest (2004) 1.31
Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry (2004) 1.30
The clonal evolution of metastases from primary serous epithelial ovarian cancers. Int J Cancer (2009) 1.29
Establishment of cereal endosperm expression domains: identification and properties of a maize transfer cell-specific transcription factor, ZmMRP-1. Plant Cell (2002) 1.27
Concordance between adolescent reports of childhood abuse and Child Protective Service determinations in an at-risk sample of young adolescents. Child Maltreat (2008) 1.26
17-Beta-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. Proc Natl Acad Sci U S A (2009) 1.24
Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors. Eur J Immunol (2002) 1.21
Tumour-associated macrophages and cancer. Curr Opin Pharmacol (2013) 1.20
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother Pharmacol (2013) 1.19
Promoting patient participation in consultations: a randomised controlled trial to evaluate the effectiveness of three patient-focused interventions. Patient Educ Couns (2004) 1.16
Optimizing TILLING populations for reverse genetics in Medicago truncatula. Plant Biotechnol J (2009) 1.16
Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol (2005) 1.15
Premature deaths after discharge from methadone maintenance: a replication. J Addict Med (2007) 1.14
Multicomponent semiconducting polymer systems with low crystallization-induced percolation threshold. Nat Mater (2006) 1.14
Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry (2004) 1.13
A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res (2004) 1.13
Magnetoencephalographic recordings of visual evoked brain activity in the human fetus. Lancet (2002) 1.12
Natural killer and dendritic cell contact in lesional atopic dermatitis skin--Malassezia-influenced cell interaction. J Invest Dermatol (2002) 1.12
Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) (2005) 1.11
The pilot study of a telephone disease management program for depression. Gen Hosp Psychiatry (2003) 1.10
Biosynthesis of the halogenated auxin, 4-chloroindole-3-acetic acid. Plant Physiol (2012) 1.08
A multicenter, randomized, double-blinded, placebo-controlled phase III study of Clot Lysis Evaluation of Accelerated Resolution of Intraventricular Hemorrhage (CLEAR III). Int J Stroke (2013) 1.08
Emotional disorders in primary care. J Consult Clin Psychol (2002) 1.07
Genetic and genomic analysis of legume flowers and seeds. Curr Opin Plant Biol (2006) 1.07
The peritoneal tumour microenvironment of high-grade serous ovarian cancer. J Pathol (2012) 1.07
Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis (2006) 1.06
Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum (2008) 1.06
Effectiveness of early orthodontic treatment with the Twin-block appliance: a multicenter, randomized, controlled trial. Part 2: Psychosocial effects. Am J Orthod Dentofacial Orthop (2003) 1.05
Modeling participation in the NHII: operations research approach. AMIA Annu Symp Proc (2005) 1.03
Marital quality, coping with conflict, marital complaints, and affection in couples with a depressed wife. J Fam Psychol (2002) 1.03
Adverse childhood experiences and child health in early adolescence. JAMA Pediatr (2013) 1.02
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol (2010) 1.02
Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson (2009) 1.02
Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol (2012) 1.02
Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data. Am J Surg Pathol (2008) 1.02
The seed composition of Arabidopsis mutants for the group 3 sulfate transporters indicates a role in sulfate translocation within developing seeds. Plant Physiol (2010) 1.01
Intermittent electrical stimulation redistributes pressure and promotes tissue oxygenation in loaded muscles of individuals with spinal cord injury. J Appl Physiol (1985) (2010) 1.01
Reserve accumulation in legume seeds. C R Biol (2008) 1.01
Cancer. Sex, cytokines, and cancer. Science (2007) 1.01
Activated macrophages in the tumour microenvironment-dancing to the tune of TLR and NF-kappaB. J Pathol (2009) 1.00
A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Inst (2004) 1.00
Macrophage scavenger receptor a promotes tumor progression in murine models of ovarian and pancreatic cancer. J Immunol (2013) 1.00
Heterogeneity of the epsilon gamma delta beta-thalassaemias: characterization of three novel English deletions. Br J Haematol (2005) 1.00